SRAM
APYX icon

Stone Ridge Asset Management’s Apyx Medical APYX Stock Holding History

Stone Ridge Asset Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-13,000
Closed -$87K – 1068
2019
Q2 		$87K Buy
+13,000
New +$70.7K 0.01% 1117

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Stone Ridge Asset Management's APYX Position: Q3 2019 in Review

Stone Ridge Asset Management sold out of Apyx Medical (APYX) in Q3 2019, closing a stake of 13,000 shares — an estimated $87K sold.

Stone Ridge Asset Management first reported a position in APYX in Q2 2019 and held it in 1 quarter. The position peaked at $87K in Q2 2019. 69 funds tracked by Wall St. Rank hold APYX as of Q3 2019.

  • Stone Ridge Asset Management reported no remaining Apyx Medical position as of Q3 2019 after selling out during the quarter.
  • Stone Ridge Asset Management sold 13,000 Apyx Medical shares in Q3 2019, an estimated $87K.
  • Stone Ridge Asset Management first reported a position in Apyx Medical in Q2 2019 and held it in 1 quarter.
  • Stone Ridge Asset Management's Apyx Medical position peaked at $87K in Q2 2019.
  • 69 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2019.

Based on Stone Ridge Asset Management's 13F filing for Q3 2019, filed 8 Nov 2019.